Drug interactions
Natalizumab + Ponesimod
Severity: Major
Natalizumab and Ponesimod: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ponesimod lowers circulating lymphocyte counts, and natalizumab restricts immune cell entry into tissues. Combined use may increase the risk of serious infection, and the effect of ponesimod persists for some time after it is stopped.
What this interaction means in plain words
Natalizumab and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Natalizumab belongs to Gastrointestinal Tract; Ponesimod belongs to Central Nervous System.
Why it happens
Additive immunosuppression through S1P receptor modulation (lymphocyte sequestration) and alpha-4 integrin blockade.
What to do
Avoid concurrent use. When switching, allow for natalizumab's prolonged pharmacodynamic effect and check lymphocyte counts before starting ponesimod.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Natalizumab and Ponesimod, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Natalizumab
- Natalizumab + Vedolizumab Contraindicated
- Axicabtagene ciloleucel + Natalizumab Major
- Baricitinib + Natalizumab Major
- Belatacept + Natalizumab Major
- Brexucabtagene autoleucel + Natalizumab Major
- Cabazitaxel + Natalizumab Major
Other interactions of Ponesimod
- Fingolimod + Ponesimod Contraindicated
- Ponesimod + Siponimod Contraindicated
- Amiodarone + Ponesimod Major
- Amisulpride + Ponesimod Major
- Anagrelide + Ponesimod Major
- Anti-thymocyte + Ponesimod Major
Frequently asked questions
Can I take Natalizumab with Ponesimod?
MediHelp rates the interaction as major. Natalizumab and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ponesimod lowers circulating lymphocyte counts, and natalizumab restricts immune cell entry into tissues. Combined use may increase the risk of serious infection, and the effect of ponesimod persists for some time after it is stopped.
How serious is the interaction between Natalizumab and Ponesimod?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use. When switching, allow for natalizumab's prolonged pharmacodynamic effect and check lymphocyte counts before starting ponesimod.
What other medicines interact with Natalizumab?
MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
